{"SPADE_UN_15501": {"Clinical Information": [], "Patent Information": [], "Sequence Information": {"SPADE ID": "SPADE_UN_15501", "Peptide Name": "Wollamide B [W1D-Phe(4-Cl)]", "Source": "Synthetic", "Family": "", "Gene": "Not found", "Sequence": "XLLVNX", "Sequence Length": 6, "UniProt Entry": ["http://www.uniprot.org/uniprot/Notavailable"], "Protein Existence": "Not found", "Biological Activity": ["Antimicrobial", "Anticancer"], "Target Organism": "Tumor cells:HepG2 (IC50>100ÂµM)", "Hemolytic Activity": "Not available", "Cytotoxicity": "Not available", "Binding Target": "Not available", "Linear/Cyclic": "Cyclic", "N-terminal Modification": "Free", "C-terminal Modification": "Free", "Stereochemistry": "Mix", "Structure Description": "Not found", "Formula": "C15H22N4O2", "Mass": 37973, "PI": 6.11, "Net Charge": 0, "Hydrophobicity": 0.75, "Half Life": "Mammalian:/Yeast:/E.coli:/", "Literature": [{"Title": "Design, synthesis and structure-activity relationship study of wollamide B; a new potential anti TB agent", "Pubmed ID": "28423019", "Reference": "PLoS One. 2017 Apr 19;12(4)e0176088.", "Author": "Asfaw H, Laqua K, Walkowska AM, Cunningham F, Martinez-Martinez MS, Cuevas-Zurita JC, Ballell-Pages L, Imming P.", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=28423019"}], "Frequent Amino Acids": "LXN", "Absent Amino Acids": "ACDEFGHIKMOPQRSTUWY", "Basic Residues": 0, "Acidic Residues": 0, "Hydrophobic Residues": 3, "Polar Residues": 2, "Positive Residues": 0, "Negative Residues": 0, "Similar Sequences": [{"SPADE_ID": "SPADE_N_06816", "Similarity": 1.0, "Sequence": "WLLVNG"}, {"SPADE_ID": "SPADE_N_06820", "Similarity": 1.0, "Sequence": "WLLVN"}, {"SPADE_ID": "SPADE_N_10822", "Similarity": 1.0, "Sequence": "WWKWWKRLRRLFLLV"}]}}}